2025 Top 10 Oncology Injection Factory in China

Introduction to Oncology Injection

Oncology injection refers to injectable drugs specifically designed for the treatment of cancer. These injections play a crucial role in the fight against cancer, as they can deliver therapeutic agents directly into the bloodstream, allowing for a more targeted and effective treatment. Oncology injections can be used for various purposes, such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy. They can help to kill cancer cells, slow down their growth, or boost the body's immune system to fight against the disease. With the continuous development of medical technology, the demand for high - quality oncology injections is increasing, and many Chinese pharmaceutical factories are actively involved in their research, development, and production.

Top 10 Oncology Injection Factories in China

1. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a leading biopharmaceutical enterprise in China. It is committed to the research, development, production, and sales of genetic engineering drugs and biochemical drugs. The company has a strong R & D team and advanced production facilities, which enable it to produce high - quality oncology injection products.

Characteristics in Oncology Injection:

• Innovative R & D: The company focuses on the research and development of new oncology injection drugs. It invests a large amount of resources in exploring new drug targets and treatment mechanisms. For example, it is researching some novel immunomodulatory oncology injections that can enhance the body's immune response to cancer cells more specifically.
• Quality Control: Jiuyuan has a strict quality control system throughout the production process of oncology injections. From the selection of raw materials to the final product inspection, every step is carefully monitored to ensure the safety and efficacy of the drugs.
• Diversified Product Portfolio: It offers a variety of oncology injection products to meet different clinical needs. These products cover different types of cancer treatments, including chemotherapy - related injections and some targeted therapy drugs.

Advantages:

• Technical Expertise: The company has in - depth technical knowledge in genetic engineering and biopharmaceutical production. This expertise allows it to develop and produce complex oncology injection drugs with high precision.
• Industry Reputation: Over the years, Jiuyuan has established a good reputation in the pharmaceutical industry. Its products are widely recognized by doctors and patients, which gives it an edge in the market competition.
• Research Partnerships: It has established partnerships with many domestic and international research institutions. These partnerships facilitate the exchange of scientific knowledge and resources, promoting the continuous innovation of oncology injection products.

Website: https://www.jiuyuangene.net/

2. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd. is one of the largest and most well - known pharmaceutical companies in China. It has a long - standing history of research and development in the field of oncology.

Company Introduction:Hengrui Medicine was founded in 1970 and has grown into a comprehensive pharmaceutical enterprise with a global vision. The company has a large - scale R & D center and production base. It is committed to the research, development, production, and sales of innovative drugs, including oncology injections. Hengrui has a strong R & D team composed of thousands of professional researchers, including many well - known experts in the field of oncology. The company has also made significant investments in building advanced production facilities that comply with international quality standards.

Characteristics in Oncology Injection:

• High - end R & D: Hengrui is at the forefront of oncology injection R & D in China. It focuses on developing first - in - class and best - in - class oncology drugs. For example, it has developed several innovative oncology injection drugs that have shown excellent clinical efficacy in the treatment of various cancers, such as breast cancer, lung cancer, and gastric cancer.
• Global Clinical Trials: The company actively conducts global clinical trials for its oncology injection products. This not only helps to evaluate the safety and efficacy of the drugs in different populations but also promotes the internationalization of its products.
• Continuous Innovation: Hengrui is constantly exploring new treatment concepts and technologies in oncology. It invests a large proportion of its revenue in R & D, which enables it to continuously launch new and improved oncology injection products.

Advantages:

• Strong Financial Support: With its large - scale business operations and high - quality product sales, Hengrui has strong financial resources. This allows it to invest heavily in R & D, clinical trials, and production expansion, ensuring the continuous development of oncology injection products.
• Comprehensive Product Pipeline: The company has a rich product pipeline in the field of oncology. It has multiple oncology injection drugs in different stages of R & D, which provides a long - term guarantee for its market competitiveness.
• International Recognition: Hengrui's oncology injection products have gained international recognition. Some of its drugs have been approved for marketing in many countries, which enhances its brand image and market share globally.

3. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical is a large - scale pharmaceutical group with a wide range of business operations, including oncology injection production.

Company Introduction:Fosun Pharmaceutical was established in 1994. It has a diversified business model that covers pharmaceutical R & D, production, and sales, as well as medical services. In the field of oncology, the company has made significant progress in recent years. It has a global R & D network and a large - scale production base. Fosun Pharmaceutical also actively promotes the integration of traditional Chinese medicine and Western medicine in oncology treatment.

Characteristics in Oncology Injection:

• Integrated R & D and Production: Fosun Pharmaceutical has established an integrated R & D and production system for oncology injections. This allows for better coordination between R & D and production, ensuring the timely launch of new products.
• Combination Therapy Focus: The company pays attention to the development of combination therapy oncology injection products. By combining different drugs, it aims to improve the treatment effect and reduce the side effects of cancer treatment.
• International Cooperation: Fosun Pharmaceutical has established extensive international cooperation in the field of oncology. It has partnered with many international pharmaceutical companies and research institutions to introduce advanced technologies and products.

Advantages:

• Diversified Business Portfolio: The company's diversified business portfolio provides it with multiple sources of revenue and resources. This can support the R & D and production of oncology injection products more stably.
• Brand Influence: Fosun Pharmaceutical has a well - known brand in the pharmaceutical industry. Its brand influence helps to promote the sales and acceptance of its oncology injection products.
• Medical Service Integration: The integration of medical services allows Fosun Pharmaceutical to have a better understanding of clinical needs. This can guide the R & D direction of oncology injection products and improve the overall treatment experience for patients.

4. BeiGene, Ltd.

BeiGene is a global biotechnology company focused on the discovery, development, and commercialization of innovative cancer therapies, including oncology injections.

Company Introduction:Founded in 2010, BeiGene has quickly grown into a leading player in the global oncology field. It has R & D centers in multiple countries and regions, including the United States, China, and Europe. The company is committed to developing high - quality oncology drugs that can address unmet medical needs.

Characteristics in Oncology Injection:

• Global R & D Strategy: BeiGene's global R & D strategy enables it to access a wide range of resources and talent. It conducts clinical trials in different regions to ensure the global applicability of its oncology injection products.
• Focus on Immuno - Oncology: The company has a strong focus on immuno - oncology research. It is developing several oncology injection drugs that target the immune system to enhance the body's ability to fight cancer.
• Fast - Track Development Process: BeiGene has a relatively fast - track development process for its oncology injection products. It uses advanced technologies and innovative trial designs to accelerate the R & D cycle.

Advantages:

• Innovative Culture: The company has an innovative culture that encourages employees to explore new ideas and technologies. This has led to the development of several breakthrough oncology injection drugs.
• Global Market Access: BeiGene's global presence gives it access to a large market. It can quickly commercialize its oncology injection products in different countries, which helps to recoup R & D costs and gain market share.
• Strong Investor Support: BeiGene has received strong support from investors. This financial support allows it to continue to invest in R & D and expand its business operations.

5. Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group is a well - established pharmaceutical company in China with a focus on oncology research and production.

Company Introduction:The company has a long - standing history of pharmaceutical production. It has a complete industrial chain from raw material production to drug formulation. In the field of oncology, Chia Tai Tianqing has been committed to developing safe and effective oncology injection products. It has a professional R & D team and advanced production equipment.

Characteristics in Oncology Injection:

• Traditional Chinese Medicine Integration: Chia Tai Tianqing combines traditional Chinese medicine theory with modern pharmaceutical technology in the development of oncology injection products. Some of its products are based on traditional Chinese medicine ingredients, which have shown unique advantages in cancer treatment.
• Quality - Oriented Production: The company adheres to strict quality control standards in the production of oncology injections. It has established a comprehensive quality management system to ensure the stability and reliability of product quality.
• Market - Oriented R & D: Chia Tai Tianqing conducts market - oriented R & D. It closely monitors market demand and clinical needs to develop oncology injection products that are more suitable for the market.

Advantages:

• Rich Experience in Traditional Chinese Medicine: The company's experience in traditional Chinese medicine provides it with a unique perspective in oncology research. It can develop oncology injection products with different mechanisms of action compared to pure Western - style drugs.
• Stable Supply Chain: Chia Tai Tianqing has a stable supply chain for raw materials. This ensures the continuous production of oncology injection products and reduces the risk of supply shortages.
• Local Market Advantage: It has a good understanding of the local market in China. This allows it to better meet the needs of Chinese patients and doctors, and gain a competitive edge in the domestic oncology injection market.

6. Qilu Pharmaceutical Co., Ltd.

Qilu Pharmaceutical is a large - scale pharmaceutical enterprise in China with a significant presence in the oncology injection field.

Company Introduction:Qilu Pharmaceutical was founded in 1953. It has a long - standing history of pharmaceutical production and has gradually developed into a comprehensive pharmaceutical company. The company has a large - scale R & D center and production base. It is committed to providing high - quality oncology injection products at an affordable price.

Characteristics in Oncology Injection:

• Cost - Effective Production: Qilu Pharmaceutical focuses on cost - effective production of oncology injection products. Through advanced production technology and efficient management, it can reduce production costs while maintaining high product quality.
• Wide Product Range: The company offers a wide range of oncology injection products, covering different types of cancer treatments. This allows it to meet the diverse needs of patients and medical institutions.
• Continuous Quality Improvement: Qilu Pharmaceutical is constantly improving the quality of its oncology injection products. It invests in new production equipment and quality control systems to ensure the safety and efficacy of the drugs.

Advantages:

• Large - Scale Production Capacity: With its large - scale production base, Qilu Pharmaceutical can produce a large quantity of oncology injection products. This helps to meet the market demand and also gives it an advantage in terms of economies of scale.
• Price Competitiveness: The cost - effective production model enables the company to offer its oncology injection products at a relatively low price. This makes its products more accessible to patients, especially in developing regions.
• Long - Standing Industry Reputation: Qilu Pharmaceutical has a long - standing reputation in the pharmaceutical industry. Its products are trusted by doctors and patients, which helps to maintain its market share in the oncology injection market.

7. Shenzhen Neptunus Bio - Pharm Co., Ltd.

Shenzhen Neptunus Bio - Pharm is a biopharmaceutical company that focuses on oncology research and development, especially in the production of oncology injection drugs.

Company Introduction:The company was established in 1992. It is mainly engaged in the research, development, production, and sales of biopharmaceutical products. In the field of oncology, Neptunus Bio - Pharm has a strong R & D team and advanced production technology. It is committed to developing innovative oncology injection products based on biotechnology.

Characteristics in Oncology Injection:

• Biotechnology - Based R & D: Neptunus Bio - Pharm uses advanced biotechnology in the R & D of oncology injection products. It focuses on the development of drugs that target specific biological molecules in cancer cells, such as monoclonal antibodies and cytokines.
• Personalized Medicine Exploration: The company is exploring the field of personalized medicine in oncology. It aims to develop oncology injection products that can be tailored to the individual genetic characteristics of patients, improving the treatment effect.
• Collaborative R & D: Neptunus Bio - Pharm actively collaborates with domestic and international research institutions and universities. This collaborative R & D model helps to integrate different resources and expertise, promoting the innovation of oncology injection products.

Advantages:

• Biotechnology Expertise: The company's expertise in biotechnology gives it an advantage in developing high - tech oncology injection products. It can develop drugs with high specificity and low side effects.
• Focus on Innovation: Neptunus Bio - Pharm has a strong focus on innovation. It invests a large amount of resources in R & D to develop new oncology injection drugs, which helps it to stay ahead in the market competition.
• Market Potential in Personalized Medicine: The exploration of personalized medicine in oncology gives the company a large market potential. As the concept of personalized medicine becomes more popular, its oncology injection products may gain more market share.

8. Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical is a well - known pharmaceutical company in China with a long - standing history in oncology drug production.

Company Introduction:Hisun Pharmaceutical was founded in 1956. It has a comprehensive pharmaceutical business that includes R & D, production, and sales. In the oncology field, the company has a wide range of oncology injection products. It has a large - scale R & D center and production base, and is committed to providing high - quality oncology drugs to patients.

Characteristics in Oncology Injection:

• Backward Integration: Hisun Pharmaceutical has achieved backward integration in the production of oncology injection products. It has its own production facilities for raw materials, which helps to control the quality and cost of the products.
• Continuous Product Upgrading: The company is constantly upgrading its oncology injection products. It uses new technologies and research findings to improve the efficacy and safety of the drugs.
• International Market Expansion: Hisun Pharmaceutical actively expands its international market for oncology injection products. It has obtained approvals for its products in many countries and regions, promoting the internationalization of its brand.

Advantages:

• Raw Material Self - Sufficiency: The backward integration in raw material production gives the company greater control over the production process. It can ensure the stable supply of raw materials and reduce the impact of external market fluctuations on production.
• Product Upgrading Ability: The company's ability to continuously upgrade its products allows it to keep up with the latest trends in oncology treatment. This helps to maintain its competitiveness in the market.
• International Market Penetration: Hisun Pharmaceutical's success in international market expansion gives it a broader market space. It can gain more experience and resources from the international market, promoting the further development of its oncology injection business.

9. CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group is a leading pharmaceutical company in China with a significant contribution to the oncology injection field.

Company Introduction:CSPC was established in 1995. It is a comprehensive pharmaceutical company with a focus on R & D, production, and sales of pharmaceutical products. In the oncology area, the company has a strong R & D team and advanced production facilities. It is committed to developing innovative oncology injection products to meet the unmet medical needs of cancer patients.

Characteristics in Oncology Injection:

• Targeted Therapy Focus: CSPC Pharmaceutical Group focuses on the development of targeted therapy oncology injection products. It aims to develop drugs that can specifically target cancer - related molecules, improving the treatment precision and reducing side effects.
• Quality - Driven R & D: The company adheres to a quality - driven R & D approach. It conducts strict pre - clinical and clinical studies to ensure the safety and efficacy of its oncology injection products.
• Digital Transformation in R & D: CSPC is actively promoting digital transformation in its oncology injection R & D. It uses big data and artificial intelligence technologies to optimize the R & D process and improve the success rate of drug development.

Advantages:

• Targeted Therapy Expertise: The company's focus on targeted therapy gives it an edge in the oncology market. Targeted therapy drugs have shown better clinical efficacy and fewer side effects, which are highly demanded by patients and doctors.
• Quality Assurance: The quality - driven R & D approach ensures the high quality of CSPC's oncology injection products. This helps to build a good brand image and gain the trust of the market.
• Digital Innovation Advantage: The digital transformation in R & D allows the company to be more efficient and innovative. It can quickly respond to the latest research findings and market needs, promoting the development of new oncology injection products.

10. Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences is a biotechnology company dedicated to the research, development, and commercialization of innovative oncology drugs, including oncology injections.

Company Introduction:Junshi Biosciences was founded in 2012. It has a world - class R & D team and advanced production facilities. The company focuses on the development of immuno - oncology drugs, which have shown great potential in cancer treatment. It is committed to bringing high - quality oncology injection products to patients around the world.

Characteristics in Oncology Injection:

• Immuno - Oncology Leadership: Junshi Biosciences is a leader in the field of immuno - oncology injection R & D. It has developed several innovative immuno - oncology drugs that have shown excellent clinical results in the treatment of various cancers.
• Global Clinical Trials Strategy: The company actively conducts global clinical trials for its oncology injection products. This helps to evaluate the safety and efficacy of the drugs in different populations and promotes the internationalization of its products.
• Continuous Innovation in Immuno - Oncology: Junshi Biosciences is constantly exploring new immuno - oncology treatment concepts and technologies. It invests a large amount of resources in R & D to develop more effective and safer oncology injection products.

Advantages:

• Immuno - Oncology Expertise: The company's expertise in immuno - oncology gives it a unique position in the oncology market. Immuno - oncology drugs have the potential to revolutionize cancer treatment, and Junshi Biosciences is at the forefront of this field.
• Global Clinical Trial Experience: The company's experience in global clinical trials allows it to better understand the international market and regulatory requirements. This helps to promote the smooth launch of its oncology injection products in different countries.
• Innovation - Driven Culture: Junshi Biosciences has an innovation - driven culture. This encourages its researchers to explore new ideas and technologies, which is crucial for the continuous development of high - quality oncology injection products.

Summary

The top 10 oncology injection factories in China, as introduced above, play a crucial role in the fight against cancer. Each company has its own unique characteristics and advantages in the field of oncology injection research, development, and production. Some companies, like Jiangsu Hengrui Medicine and BeiGene, are at the forefront of global oncology R & D, with a focus on developing innovative drugs and conducting international clinical trials. Others, such as Chia Tai Tianqing Pharmaceutical Group, combine traditional Chinese medicine and Western medicine, providing unique treatment options.

These companies not only contribute to the domestic oncology treatment market but also have a growing influence on the global stage. They are constantly striving for innovation, improving product quality, and expanding their market share. With the continuous development of medical technology and the increasing demand for oncology treatment, these top 10 factories are expected to play an even more important role in the future, bringing more hope to cancer patients around the world.